Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 4/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.48 |
| ▸ | ESR1 | P03372 | 2/20 | 0.43 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.43 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.43 |
| ▸ | TACR2 | P21452 | 2/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | SHBG | P04278 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.43 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.43 |
| ▸ | HTR2C | P28335 | 1/20 | 0.43 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1188450 | 0.98 | PTGS2 (0.52) | PTGS2CYP3A4GPR84ESR1ADRA2A | |
| SCHEMBL1186069 | 0.98 | PTGS2 (0.52) | PTGS2CYP3A4GPR84ESR1ADRA2A | |
| SCHEMBL1188332 | 0.98 | PTGS2 (0.52) | PTGS2CYP3A4GPR84ESR1ADRA2A | |
| SCHEMBL1186650 | 0.98 | PTGS2 (0.52) | PTGS2CYP3A4GPR84ESR1ADRA2A | |
| SCHEMBL1187306 | 0.98 | PTGS2 (0.52) | PTGS2CYP3A4GPR84ESR1ADRA2A | |
| SCHEMBL1186516 | 0.98 | PTGS2 (0.52) | PTGS2CYP3A4GPR84ESR1ADRA2A | |
| SCHEMBL829394 | 0.98 | PTGS2 (0.52) | PTGS2CYP3A4GPR84ESR1ADRA2A | |
| SCHEMBL1187331 | 0.98 | PTGS2 (0.52) | PTGS2CYP3A4GPR84ESR1ADRA2A | |
| SCHEMBL1187072 | 0.98 | PTGS2 (0.52) | PTGS2CYP3A4GPR84ESR1ADRA2A | |
| SCHEMBL1187009 | 0.98 | PTGS2 (0.52) | PTGS2CYP3A4GPR84ESR1ADRA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8901336-B2 | Catalysts, methods of making catalysts, and methods of use | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2014-12-02 | — | — | US | claimed |
| US-20130060056-A1 | CATALYSTS, METHODS OF MAKING CATALYSTS, AND METHODS OF USE | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2013-03-07 | — | — | US | claimed |
| US-7161018-B2 | Soluble late transition metal catalysts for olefin oligomerizations II | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2007-01-09 | — | — | US | claimed |
| EP-1513854-B1 | SOLUBLE LATE TRANSITION METAL CATALYSTS FOR OLEFIN OLIGOMERIZATIONS | EXXONMOBIL CHEM PATENTS INC (US) | 2006-11-29 | — | — | EP | claimed |
| US-20210074956-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | GU'AN YEOLIGHT TECHNOLOGY CO., LTD. (CN) | 2021-03-11 | — | — | US | disclosed |
| EP-2746271-B1 | Phenyl-substituted 1, 3, 5-triazine compounds as intermediates for electroluminescent molecules | TOSOH CORP (JP) | 2016-08-17 | — | — | EP | disclosed |
| US-8901336-B2 | Catalysts, methods of making catalysts, and methods of use | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2014-12-02 | — | — | US | disclosed |
| EP-2746271-A1 | Phenyl-substituted 1, 3, 5-triazine compounds as intermediates for electroluminescent molecules | Tosoh Corporation (JP) | 2014-06-25 | — | — | EP | disclosed |
| EP-2141158-B1 | PHENYL-SUBSTITUTED 1,3,5-TRIAZINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND ORGANIC ELECTROLUMINESCENT DEVICE CONTAINING THE SAME AS COMPONENT | TOSOH CORP (JP) | 2014-05-07 | — | — | EP | disclosed |
| US-8569485-B2 | Phenyl-substituted 1,3,5-triazine compound, process for producing the same, and organic electroluminescent device containing the same as component | TOSOH CORPORATION (JP) | 2013-10-29 | — | — | US | disclosed |
| US-8530687-B2 | Catalysts, methods of making catalysts, and methods of use | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2013-09-10 | — | — | US | disclosed |
| US-8481736-B2 | Liquid crystalline rylene tetracarboxylic acid derivatives and use thereof | BASF SE (DE) | 2013-07-09 | — | — | US | disclosed |
| WO-2007116001-A2 | LIQUID CRYSTALLINE RYLENE TETRACARBOXYLIC ACID DERIVATIVES AND USE THEREOF | BASF SE (DE) | 2007-10-18 | — | — | WO | disclosed |
| EP-1843407-A1 | Liquid crystalline rylenetetracarboxylic acid derivatives and their use | BASF AKTIENGESELLSCHAFT (DE) | 2007-10-10 | — | — | EP | disclosed |
| US-7161018-B2 | Soluble late transition metal catalysts for olefin oligomerizations II | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2007-01-09 | — | — | US | disclosed |
| EP-1513854-B1 | SOLUBLE LATE TRANSITION METAL CATALYSTS FOR OLEFIN OLIGOMERIZATIONS | EXXONMOBIL CHEM PATENTS INC (US) | 2006-11-29 | — | — | EP | disclosed |
| US-6562485-B2 | Electroluminescent (EL) devices | XEROX CORPORATION | 2003-05-13 | — | — | US | disclosed |
| US-20030044646-A1 | Electroluminescent (EL) devices | XEROX CORPORATION | 2003-03-06 | — | — | US | disclosed |
| US-6479172-B2 | PERFORMANCE, THERMOSTABILITY | XEROX CORPORATION | 2002-11-12 | — | — | US | disclosed |
| US-20020132134-A1 | Electroluminescent (EL) devices | XEROX CORPORATION | 2002-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130060056-A1 | CATALYSTS, METHODS OF MAKING CATALYSTS, AND METHODS OF USE | SOD1, CAT, APEX1 | PTGS2 2296/4885CYP3A4 2502/4885GPR84 4868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.